ClinicalTrials.gg
RecruitingNCT07618884Updated Jun 1, 2026

TransREctus Sheath PrePeritoneal Procedure (TREPP) for Inguinal Hernia Repair

An interventional study of trans rectus sheath extra-peritoneal procedure (TREPP) in Inguinal Hernia and Inguinal Hernia Repair, sponsored by Assiut University. Recruiting at 1 site in Egypt. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-06-01.

Sponsored by Assiut University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Jun 2026, 5 months ago, but the record still lists the study as recruiting.
  • Registered 1 year 1 month after the study started (first participant enrolled Apr 2025, registered May 2026).
  • Started Apr 2025; still recruiting 1 year 7 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 12 studies in Hernia, Inguinal by Assiut University — 9 open to participants now, 9 under way, none of them phase 3. Hernia, Inguinal · Assiut University.

Planned enrollment
7th of 10
30 · median 60
Started
2025
with 1 other
No phase
8 of 12
7 open now
Registered
10th of 12
by date

Among the 12 studies in Hernia, Inguinal by Assiut University, this one is the 7th largest by planned enrollment of the 10 interventional ones that give a count, is one of 2 that started in 2025, is one of 8 with no phase, and was the 10th registered.

Hernia, Inguinal

545 studies on the registry are indexed under Hernia, Inguinal; 91 are open to participants now.

Browse Hernia, Inguinal studies →

Open to participants now

9 of the 12 studies in Hernia, Inguinal by Assiut University are open now, in 1 country. Recruiting first, the newest first:

3 more — sign in →

By country, each count listing its studies:

All 9 open studies →

Where they have run

Who these studies take

Of the 54 Hernia, Inguinal studies recruiting now, 30 (56%) set no upper age limit and 16 (30%) stop at 75 or younger; 16 take children under 18; 9 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 12 studies in Hernia, Inguinal by Assiut University, or all of them as a file.
02

Study summary

Inguinal hernia repair remains one of the most commonly performed surgical procedures worldwide. Tension-free repair with mesh augmentation is the predominant treatment option, either achieved by preperitoneal laparoscopic hernioplasty or Lichtenstein procedure (LP). As the recurrence rate is reduced to less than 5 % after mesh repair, nowadays, long-term morbidity associated with open inguinal hernia repair is mainly related to chronic postoperative inguinal pain (CPIP). Despite many hypotheses about the possible causes for CPIP, there is now consensus that involvement of inguinal nerves plays a major role.

The trans rectus sheath extra-peritoneal procedure (TREPP) is a minimally invasive open approach utilizing the rectus sheath to access the preperitoneal space. It has shown promise in providing effective repair with potential advantages in cosmesis, postoperative pain, and recurrence rates. It is a medial approach avoiding the interference with the course of all (three) inguinal nerves through lateral abdominal wall.

Read the detailed description

This is a prospective cohort study

03

Conditions studied

  • Inguinal Hernia
  • Inguinal Hernia Repair

Browse trials for

Keywords

  • Inguinal hernia
  • Chronic postoperative inguinal pain
  • Trans rectus sheath extra-peritoneal procedure
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults with primary unilateral or bilateral inguinal hernia

Exclusion criteria

Exclusion Criteria:

  • Strangulated hernias.
  • Severe comorbidities precluding surgery ((ASA Class IV,V)
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    TREPP group

    Patients undergoing TransREctus Sheath PrePeritoneal Procedure (TREPP) for inguinal hernia repair

    Procedure: trans rectus sheath extra-peritoneal procedure (TREPP)

Interventions

  • Proceduretrans rectus sheath extra-peritoneal procedure (TREPP)

    The TREPP technique, a minimally invasive open approach utilizing the rectus sheath to access the preperitoneal space

06

What researchers measure

Primary outcomes

  1. Recurrence rate

    Number and percentage of patients with recurrence of hernia after surgery

    Time frame: through study completion, an average of 1 year

Secondary outcomes

  1. Incidence of chronic postoperative inguinal pain

    Number and percentage of patients with groin pain that lasts more than three months after inguinal hernia surgery

    Time frame: 3 months after surgery

07

Study locations

1 of 1 sites recruiting
  • Faculty of Medicine-Assiut University -Assiut-Egypt
    Asyut, Asyut Governorate 71515, Egypt
    Recruiting
    • Mohamad Raafat, MD · Contact
08

References and documents

Publications

  • Faessen JL, Stoot JHMB, Broos PPHL, Vijgen GHEJ, Reisinger KW, Bouvy ND, van Vugt R. Trans rectus sheath extra-peritoneal procedure (TREPP) for inguinal hernia repair under local anesthesia with sedation in the outpatient clinic: a feasibility study. Langenbecks Arch Surg. 2024 Jun 19;409(1):188. doi: 10.1007/s00423-024-03383-z. PubMed 38896330 ↗
  • Bokkerink WJ, Persoon AM, Akkersdijk WL, van Laarhoven CJ, Koning GG. The TREPP as alternative technique for recurrent inguinal hernia after Lichtenstein's repair: A consecutive case series. Int J Surg. 2017 Apr;40:73-77. doi: 10.1016/j.ijsu.2017.02.022. Epub 2017 Feb 20. PubMed 28219816 ↗
  • Faessen JL, Stoot JHMB, van Vugt R. Safety and efficacy in inguinal hernia repair: a retrospective study comparing TREPP, TEP and Lichtenstein (SETTLE). Hernia. 2021 Oct;25(5):1309-1315. doi: 10.1007/s10029-020-02361-w. Epub 2021 Jan 5. PubMed 33400030 ↗
  • Bokkerink WJV, Koning GG, Vriens PWHE, Mollen RMHG, Harker MJR, Noordhof RK, Akkersdijk WL, van Laarhoven CJHM. Open Preperitoneal Inguinal Hernia Repair, TREPP Versus TIPP in a Randomized Clinical Trial. Ann Surg. 2021 Nov 1;274(5):698-704. doi: 10.1097/SLA.0000000000005130. PubMed 34342299 ↗
  • Eklund AS, Montgomery AK, Rasmussen IC, Sandbue RP, Bergkvist LA, Rudberg CR. Low recurrence rate after laparoscopic (TEP) and open (Lichtenstein) inguinal hernia repair: a randomized, multicenter trial with 5-year follow-up. Ann Surg. 2009 Jan;249(1):33-8. doi: 10.1097/SLA.0b013e31819255d0. PubMed 19106673 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2025 (actual). Primary completion is estimated for Jun 2026, 14 months after the start.

Of 179 non-industry interventional studies with no phase under Hernia, Inguinal, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 35. This study's planned 14 months is below that.

Counting every sponsor, half of 188 studies reached it within 19 months; a quarter within 9 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
May 23, 2026
First posted
Jun 1, 2026
StartActual
Apr 15, 2025
Primary completionEst.
Jun 2026
CompletionEst.
Sep 2026
Last update
Jun 1, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 1, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07618884
Lead sponsor
Assiut University
Responsible party
Mohamad Raafat (Lecturer at General surgery department, Assiut University) — Principal investigator
First posted
Jun 1, 2026
Start date
Apr 15, 2025
Primary completion
Jun 2026 (estimated)
Completion
Sep 2026 (estimated)
Last update
Jun 1, 2026

Study contacts

Mohamad Raafat, MD
Contact
mohamad_raafat10@yahoo.com
0201067877622
Faculty of Medicine-Assiut University
Contact

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion